Drug factory · FDA FEI 3005256484
Aarti Pharmalabs Limited
Unit - IV, Plot No: E - 50, 50/1, 59/1, M.I.D.C. Tarapur, Taluka & District: Palghar, Tarapur, India
Problems found, fixed voluntarily at FDA's last inspection, Mar 27, 2026.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
5 drug inspections on record since 2011: 0 with no problems, 5 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| 2-Mercaptoethanesulfonic Acid | Makes the active ingredient | AuroMedics Pharma LLC | 55150-520 |
| Fluticasone | Makes the active ingredient | Morton Grove Pharmaceuticals, Inc. | 60432-264 |
| Levalbuterol | Makes the active ingredient | Aurobindo Pharma Limited | 65862-942 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Mar 27, 2026 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Feb 20, 2020 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Dec 21, 2016 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Mar 27, 2015 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Sep 29, 2011 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: api manufacture.